Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDX..L Regulatory News (DX.)

  • There is currently no data for DX.

Amendment to Performance Share Plan

14 Dec 2022 10:45

RNS Number : 6814J
DX (Group) PLC
14 December 2022
 

AIM: DX.

DX (Group) plc

("DX" or "the Group" or "the Company")

 

Company Performance Share Plan

 

DX, the provider of delivery solutions, including parcel freight, secure courier and logistics services, reports an amendment ("Amendment") to the Performance Condition of the Company's Performance Share Plan ("PSP"), which was established in December 2017 for directors and certain senior management of the Company ("Participants").

 

The Amendment introduces a further testing date of 21 December 2023, with the objective of retaining and fairly rewarding the 36 Participants, who are currently employed by the Group, in the PSP for a further year. The current third and final testing date for the PSP is on 21 December 2022 and the Amendment therefore extends the Performance Condition and adds a further measurement date in twelve months' time.

 

In light of the close proximity of the date of restoration of the Company's ordinary shares to trading on 19 October 2022 and the third testing date for the PSP under the plan on 21 December 2022, the Amendment creates additional time for the continued strong trading by the Group and its positive outlook to be recognised in a fair market price.

 

The Amendment also provides the further benefit of enabling DX to defer the implementation of a replacement Long Term Incentive Plan for a year and will help to retain and motivate the senior managers in the PSP.

 

A majority of shareholders of the Company's issued share capital, were consulted with respect to the Amendment.

 

Related party transaction

 

Under the AIM Rules for Companies, the Amendment to the PSP in relation to David Mulligan, Paul Ibbetson, Martin Illidge, Michael Sherry, and Kevin Galligan is classified as a Related Party Transaction. Accordingly, Mark Hammond, Mike Russell and Jon Kempster as Independent Directors consider, having consulted with finnCap, the Company's Nominated Adviser, that the terms of the Amendment are fair and reasonable insofar as its shareholders are concerned.

 

Enquiries:

DX (Group) plc

T: 020 3178 6378 (c/o KTZ

Jon Kempster, Senior Independent Non-executive Director

 Communications)

Mike Russell, Independent Non-executive Director

finnCap (Nominated Adviser & Joint Broker to DX)

T: 020 7220 0500

Matt Goode/Simon Hicks (Corporate Finance)

Andrew Burdis/Charlotte Sutcliffe (ECM)

 

Liberum (Joint Broker to DX)

T: 020 3100 2000

Nick How/William Hall

 

 

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis

Dan Mahoney

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEANALFELAFEA
Date   Source Headline
26th Oct 202012:36 pmRNSDirector Share Purchase
21st Oct 20207:00 amRNSDX Expands Depot Network with New Burnley Site
19th Oct 20208:50 amRNSNotice of AGM and Annual Report and Accounts
16th Oct 202012:23 pmRNSHolding(s) in Company
14th Oct 20203:05 pmRNSAppointment of Auditor
29th Sep 20207:00 amRNSDirector Share Purchase
28th Sep 20208:23 amRNSDirector Share Purchase
21st Sep 202012:08 pmRNSDirector Share Purchase
18th Sep 202011:24 amRNSDirector Share Purchase - Replacement
17th Sep 20204:31 pmRNSDirector Share Purchase
17th Sep 20207:00 amRNSPreliminary Results
10th Sep 20207:50 amRNSExpands depot network with two new sites
14th Jul 20207:00 amRNSTrading Update
9th Jul 20207:00 amRNSJoins consortium to deliver COVID-19 testing kits
3rd Jul 20204:36 pmRNSHolding(s) in Company
2nd Jul 20202:06 pmRNSSecond Price Monitoring Extn
2nd Jul 20202:00 pmRNSPrice Monitoring Extension
2nd Jul 20208:00 amRNSPDMR Share Purchase
1st Jul 202011:35 amRNSDirector Share Purchase
30th Jun 20204:17 pmRNSDirector Share Purchase
29th Jun 20209:06 amRNSDirector Share Purchase
15th Jun 20207:00 amRNSDirector Share Purchase
8th Jun 20207:00 amRNSLaunching an Expanded DX Express Centre in Ipswich
5th Jun 20207:00 amRNSDirector Share Purchase
29th May 202012:11 pmRNSDirector/PDMR Shareholding
28th May 20204:07 pmRNSCompany Secretary Share Purchase
28th May 20207:00 amRNSTrading Update
27th Apr 202010:27 amRNSDirector Share Purchase
17th Apr 20202:15 pmRNSDirector Share Purchase
16th Apr 20207:00 amRNSTrading and Coronavirus Update
1st Apr 20207:00 amRNSHolding(s) in Company
23rd Mar 20207:00 amRNSDirector/PDMR Shareholding
19th Mar 20207:00 amRNSDirector/PDMR Shareholding
3rd Mar 20207:00 amRNSAppointment of Joint Broker
3rd Mar 20207:00 amRNSInterim Results
24th Feb 20207:00 amRNSNotice of Interim Results
4th Feb 20207:00 amRNSTrading update
3rd Jan 202012:40 pmRNSHolding(s) in Company
28th Nov 201912:38 pmRNSResult of AGM
28th Nov 20197:00 amRNSAGM Statement
15th Oct 201912:41 pmRNSReplacement: Notice of AGM
15th Oct 20198:06 amRNSNotice of AGM
24th Sep 20197:00 amRNSPreliminary Results
23rd Jul 20197:00 amRNSPre-close Trading Update
3rd Jul 20191:30 pmRNSDirector/PDMR Shareholding
29th May 20194:35 pmRNSPrice Monitoring Extension
28th May 20197:00 amRNSHMPO Contract and Trading Update
16th Apr 201912:41 pmRNSDirector/PDMR Shareholding
26th Mar 20195:52 pmRNSHolding(s) in Company
5th Mar 20197:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.